These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8693956)

  • 1. [Intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma].
    Mori H; Miyaji B; Takahashi M; Matsuda K; Tsuka H; Wada O; Aoki Y; Akino H; Muranaka K; Kanamaru H; Okada K; Imamura Y
    Hinyokika Kiyo; 1996 Apr; 42(4):257-61. PubMed ID: 8693956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Percutaneous Bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ].
    Yamashita S; Yogi Y; Taniguchi K; Morimitsu H; Suzu H; Kanetake H; Saito Y; Kubota S
    Hinyokika Kiyo; 1992 Oct; 38(10):1095-9. PubMed ID: 1481770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Squamous cell carcinoma of the renal pelvis after intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of upper urinary tract: a case report].
    Uemura M; Mukai M; Fukuhara S; Kanno N; Nishimura K; Miyoshi S; Yoshida K; Kawano K; Inoue H; Nishimura K
    Hinyokika Kiyo; 2002 Jun; 48(6):355-7. PubMed ID: 12166236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
    Okubo K; Ishitoya S; Maeda H; Suzuki Y; Arai Y
    Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):386-90. PubMed ID: 9125861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression.
    Thalmann GN; Dewald B; Baggiolini M; Studer UE
    J Urol; 1997 Oct; 158(4):1340-4. PubMed ID: 9302115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term outcome of initial treatment with Bacillus Calmette-Guérin for carcinoma in situ of the upper urinary tract].
    Kita Y; Soda T; Mizuno K; Matsuoka T; Nakanishi S; Asai S; Taoka R; Inoue K; Terai A
    Hinyokika Kiyo; 2011 Jul; 57(7):353-7. PubMed ID: 21832868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.
    Nonomura N; Ono Y; Nozawa M; Fukui T; Harada Y; Nishimura K; Takaha N; Takahara S; Okuyama A
    Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrarenal Bacillus Calmette-Guerin perfusion therapy was effective for carcinoma in situ of the upper urinary tract after ileal conduit replacement : a case report].
    Hayashi T; Yamanaka Y; Kinjo T; Katayama K; Kamoto A; Mori N; Yoshioka T
    Hinyokika Kiyo; 2014 Apr; 60(4):175-8. PubMed ID: 24882229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies of chemotherapy for patients with a solitary kidney after nephroureterectomy for advanced upper urothelial transitional cell carcinoma].
    Tsujimura A; Takayama H; Tsukikawa M; Imazu T; Sugao H; Takaha M
    Hinyokika Kiyo; 1995 Mar; 41(3):183-9. PubMed ID: 7741070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
    Thalmann GN; Markwalder R; Walter B; Studer UE
    J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study on 34 cases of urothelial cancer of upper urinary tract].
    Kyakuno M; Nojima M; Kondo N; Ito K; Sakai H; Kokado Y; Sagawa S; Shin T; Koto K
    Hinyokika Kiyo; 1987 Dec; 33(12):1995-2000. PubMed ID: 3448924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder.
    Takenaka A; Yamada Y; Miyake H; Hara I; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):309-13. PubMed ID: 18380817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Squamous cell carcinoma of the urinary bladder after intravesical bacillus Calmette-Guerin therapy for carcinoma in situ: a case report].
    Uemura M; Nishimura K; Nakagawa M; Kanno N; Miyoshi S; Kawano K; Inoue H
    Hinyokika Kiyo; 2004 Nov; 50(11):809-11. PubMed ID: 15628544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.
    Volkmer BG; Gschwend JE; Maier SH; Seidl-Schlick EM; Bach D; Romics I
    J Urol; 2003 Mar; 169(3):931-4; discussion 934-5. PubMed ID: 12576815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary carcinoma in situ of the upper urinary tract: a case report].
    Tsujimura A; Yasunaga Y; Matsumiya K; Oka T; Takaha M; Arima R; Kurata A
    Hinyokika Kiyo; 1992 May; 38(5):565-8. PubMed ID: 1609667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kidney-conservative surgery followed by bacillus Calmette-Guerin instillation therapy for transitional cell carcinoma of solitary renal pelvis: a case report].
    Ao T; Endo T; Shiokawa H; Shimura S; Adachi K; Koshiba K
    Hinyokika Kiyo; 1993 May; 39(5):463-5. PubMed ID: 8322629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
    Goel MC; Mahendra V; Roberts JG
    J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.